| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/03/2004 | WO2004046152A1 Diazinopyrimidines |
| 06/03/2004 | WO2004046146A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 06/03/2004 | WO2004046133A1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 06/03/2004 | WO2004046121A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 06/03/2004 | WO2004046092A2 Aryl sulfonamides |
| 06/03/2004 | WO2004045679A1 Peritoneal dialysis method |
| 06/03/2004 | WO2004045632A1 Peroxisome proliferator-activated recetor ligand |
| 06/03/2004 | WO2004045619A1 Freeze-dried lecithin nanometer powder injection of ursolic acid and it's preparation method |
| 06/03/2004 | WO2004045601A1 Analgesic uses of norketamine and ketamine/norketamine prodrugs |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045596A1 Method of lowering crp and reducing systemic inflammation |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004014868A3 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 06/03/2004 | WO2004014375A3 Fused bicyclic metalloproteinase inhibitors |
| 06/03/2004 | WO2003092595A3 Tyrosine kinase inhibitors |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003048153A8 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 06/03/2004 | WO2003045369A3 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | WO2003006104A8 Lymphatic endothelial cells materials and methods |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |
| 06/03/2004 | US20040106682 Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors |
| 06/03/2004 | US20040106668 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106628 CX3CR1 receptor antagonists useful in the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease and pain |
| 06/03/2004 | US20040106625 Therapeutic agents useful for treating pain |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant |
| 06/03/2004 | US20040106610 Antagonize pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors |
| 06/03/2004 | US20040106550 comprises chondromodulin-1 protein which grows articular chondrocytes by itself or under coexistence with fibroblast growth factor, and is capable of suppressing hyper degradation of cartilage matrix; gene therapy |
| 06/03/2004 | US20040106546 comprises cyclosporin, hyaluronic acid, and polysorbate compound |
| 06/03/2004 | US20040106155 Method for kidney disease treatment by drug intervention |
| 06/03/2004 | US20040105907 Anti-inflammatory effects of the partially purified extract of radix stephaniae tetrandrae |
| 06/03/2004 | CA2506704A1 Peritoneal dialysis method |
| 06/03/2004 | CA2506615A1 Analgesic uses of norketamine and ketamine/norketamine prodrugs |
| 06/03/2004 | CA2506565A1 Diazinopyrimidines |
| 06/03/2004 | CA2506025A1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 06/03/2004 | CA2505915A1 Method of lowering crp and reducing systemic inflammation |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424329A1 Method of preparing 4-(imidazole-1-il)benzenesulphonamide derivatives |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | EP1424101A2 Use of a leukotriene C4 and D4 receptor antagonist for the preparation of a medicament for treating or preventing brain inflammation and sepsis |
| 06/02/2004 | EP1424067A1 Injectable foam and novel pharmaceutical applications thereof |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423436A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 06/02/2004 | EP1423431A2 Antibodies to vla-1 |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423415A2 Intracellular signaling molecules |
| 06/02/2004 | EP1423413A1 Peptidic compounds selectively binding to p-selectin |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423409A2 Gastrokines and derived peptides including inhibitors |
| 06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 06/02/2004 | EP1423391A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 06/02/2004 | EP1423382A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423378A1 Aminopyrrole compounds as antiinflammatory agents |
| 06/02/2004 | EP1423376A1 Bicyclic compound, production and use thereof |
| 06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
| 06/02/2004 | EP1423357A2 Urea derivatives with antiproteolytic activity |
| 06/02/2004 | EP1423353A1 Substituted octahydrophenanthrene compounds and their use as nmda antagonists |
| 06/02/2004 | EP1423168A2 Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use |
| 06/02/2004 | EP1423140A2 Compositions and methods for modulation of immune responses |
| 06/02/2004 | EP1423132A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 06/02/2004 | EP1423129A1 Therapeutic process for p. aeruginosa infections using macrolide antibiotics |
| 06/02/2004 | EP1423128A2 Methods for the treatment of chronic pain anc compositions therefor |
| 06/02/2004 | EP1423121A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 06/02/2004 | EP1423117A1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 06/02/2004 | EP1326613B1 Use of substituted imidazo 1,2-a]pyridine-, imidazo [1,2-a]pyrimidine and imidazo [1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 06/02/2004 | EP1267832B1 SELF EMULSIFYING DRUG DELIVERY SYSTEM, wherein the fatty agent is optional |
| 06/02/2004 | EP1244614B1 Tryptase inhibitors |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP1171113B1 Compounds useful as phosphotyrosine mimics |
| 06/02/2004 | EP1143971B1 Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use |
| 06/02/2004 | EP1096943B1 Method of preparation and pharmaceutical composition of an uncaria water soluble extract |
| 06/02/2004 | EP0792279B1 Antibiotic cryptdin peptides and methods of their use |
| 06/02/2004 | CN1501941A Chemical compounds |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501927A Trifluoromethylpurines as phosphodiesterase 4 inhibitors |